Lynx1 Capital Management LP Diversified Active

Location: Dorado, Puerto Rico

CIK: 0001910456 · Show all filings

Period: Q1 2022 (← Previous) (Next →)

Filing Date: May 16, 2022

Total Value: $108M (100.0% shares, 0.0% debt)

Holdings (14)

— MERUS N V 21.9%

Value $23.63M Shares 893,527 Est. Cost $31.14 Unrealized —

— BELLUS HEALTH INC NEW 18.2%

Value $19.62M Shares 2,851,588 Est. Cost $7.70 Unrealized —

— ALPINE IMMUNE SCIENCES INC 12.4%

Value $13.32M Shares 1,484,693 Est. Cost $13.12 Unrealized —

— PARDES BIOSCIENCES INC 11.0%

Value $11.86M Shares 1,642,834 Est. Cost $9.46 Unrealized —

TVTX TRAVERE THERAPEUTICS INC 9.9%

Value $10.61M Shares 411,680 Est. Cost $28.16 Unrealized -5.7%

— KINNATE BIOPHARMA INC 7.2%

Value $7.798M Shares 692,508 Est. Cost $11.26 Unrealized —

— IMMUNOGEN INC 6.8%

Value $7.346M Shares 1,543,259 Est. Cost $7.42 Unrealized —

— CYMABAY THERAPEUTICS INC 4.0%

Value $4.318M Shares 1,388,505 Est. Cost $3.35 Unrealized —

— THESEUS PHARMACEUTICALS INC 3.8%

Value $4.114M Shares 356,827 Est. Cost $12.68 Unrealized —

— PIERIS PHARMACEUTICALS INC 3.2%

Value $3.443M Shares 1,136,319 Est. Cost $3.28 Unrealized —

— AEROVATE THERAPEUTICS INC 1.1%

Value $1.228M Shares 66,977 Est. Cost $18.33 Unrealized —

— PASSAGE BIO INC 0.3%

Value $327K Shares 105,504 Est. Cost $3.10 Unrealized —

— OTONOMY INC 0.1%

Value $72,000 Shares 30,000 Est. Cost $2.07 Unrealized —

— ELEVATION ONCOLOGY INC 0.0%

Value $25,000 Shares 10,000 Est. Cost $2.50 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	MERUS N V	893,527	$23.63M	21.9%	$31.14	—	COM	N5749R100
—	BELLUS HEALTH INC NEW	2,851,588	$19.62M	18.2%	$7.70	—	COM NEW	07987C204
—	ALPINE IMMUNE SCIENCES INC	1,484,693	$13.32M	12.4%	$13.12	—	COM	02083G100
—	PARDES BIOSCIENCES INC	1,642,834	$11.86M	11.0%	$9.46	—	COM	69945Q105
TVTX	TRAVERE THERAPEUTICS INC	411,680	$10.61M	9.9%	$28.16	-5.7%	COM	89422G107
—	KINNATE BIOPHARMA INC	692,508	$7.798M	7.2%	$11.26	—	COM	49705R105
—	IMMUNOGEN INC	1,543,259	$7.346M	6.8%	$7.42	—	COM	45253H101
—	CYMABAY THERAPEUTICS INC	1,388,505	$4.318M	4.0%	$3.35	—	COM	23257D103
—	THESEUS PHARMACEUTICALS INC	356,827	$4.114M	3.8%	$12.68	—	COM	88369M101
—	PIERIS PHARMACEUTICALS INC	1,136,319	$3.443M	3.2%	$3.28	—	COM	720795103
—	AEROVATE THERAPEUTICS INC	66,977	$1.228M	1.1%	$18.33	—	COM	008064107
—	PASSAGE BIO INC	105,504	$327K	0.3%	$3.10	—	COM	702712100
—	OTONOMY INC	30,000	$72,000	0.1%	$2.07	—	COM	68906L105
—	ELEVATION ONCOLOGY INC	10,000	$25,000	0.0%	$2.50	—	COM	28623U101